Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jan 21, 2022; 10(3): 870-881
Published online Jan 21, 2022. doi: 10.12998/wjcc.v10.i3.870
Table 2 Basic information of 307 patients
Basic information
Control group
Experimental group
P value
LTG
LSG
LTG
LSG
Number of cases77509981
Gender> 0.05
Male44274945
Female33235036
Age, yr60 ± 1764 ± 18> 0.05
Pathological types> 0.05
Highly differentiated adenocarcinoma14101412
Moderately differentiated adenocarcinoma23133025
Poorly differentiated adenocarcinoma29194540
Other types118104
T stage> 0.05
1101064
220113327
337224439
41071611
N stage> 0.05
11562213
229204030
333243738
CEA> 0.05
Normal44204232
Increased33305749
CA199> 0.05
Normal43245034
Increase34264947
Intraoperative blood loss (mL)71.13 ± 21.3390.70 ± 31.7761.53 ± 20.3875.69 ± 20.18< 0.05
Complication3022> 0.05
Postoperative bleeding2000
Anastomotic fistula1012
Obstruction0010
Postoperative hospital stay (d)6.55 ± 4.637.23 ± 4.516.54 ± 4.167.21 ± 4.32> 0.05